IM Cannabis Corp. Common Shares (IMCC) Stock Price

IMCCStock

$1.39−84.68%52W

Market Cap$2.29M

P/E—

PEG Ratio—

Div yield—

Beta2.25

IMCC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-66.66%

Price vs S&P 500 (4W)-34.25%

VGM Score57.04

Book Value / Share (Quarterly)$1.22

P/TBV (Annual)5.25x

Revenue Growth (3Y)16.64%

Cash Flow / Share (Quarterly)$0.89

Price vs S&P 500 (YTD)-64.64%

Gross Margin (TTM)18.58%

Net Profit Margin (TTM)-8.61%

EPS (TTM)$-1.45

10-Day Avg Trading Volume0.00M

EPS Excl Extra (TTM)$-1.45

Revenue Growth (5Y)42.88%

EPS (Annual)$-3.19

ROI (Annual)-45.52%

Gross Margin (Annual)15.64%

Net Profit Margin (5Y Avg)-123.89%

Cash / Share (Quarterly)$0.32

Revenue Growth QoQ (YoY)3.62%

ROA (Last FY)-27.01%

Revenue Growth TTM (YoY)12.68%

EBITD / Share (TTM)$-1.04

ROE (5Y Avg)-273.77%

Operating Margin (TTM)-8.16%

Cash Flow / Share (Annual)$-0.28

P/B Ratio1.08x

P/B Ratio (Quarterly)1.43x

Net Income / Employee (Annual)$-170,256

EV / Revenue (TTM)0.37x

Net Interest Coverage (TTM)-4.00x

ROA (TTM)-11.10%

EPS Incl Extra (Annual)$-3.19

Current Ratio (Annual)0.67x

Quick Ratio (Quarterly)0.59x

3-Month Avg Trading Volume0.05M

52-Week Price Return-84.68%

Revenue / Employee (TTM)$875,974

Tangible BV / Share (Quarterly)$0.53

P/S Ratio (Annual)0.11x

Asset Turnover (Annual)1.38x

52-Week High$2.24

Operating Margin (5Y Avg)-44.27%

EPS Excl Extra (Annual)$-3.19

CapEx CAGR (5Y)-36.80%

Tangible BV CAGR (5Y)-39.61%

26-Week Price Return-66.55%

Quick Ratio (Annual)0.57x

13-Week Price Return-53.88%

Total Debt / Equity (Annual)3.44x

Current Ratio (Quarterly)0.72x

Enterprise Value$14.23M

Revenue / Share Growth (5Y)51.97%

Asset Turnover (TTM)1.29x

Book Value / Share Growth (5Y)-24.15%

Revenue / Employee (Annual)$868,968

Inventory Turnover (Annual)6.91x

Pretax Margin (Annual)-23.68%

Cash / Share (Annual)$0.20

3-Month Return Std Dev107.11%

Gross Margin (5Y Avg)9.01%

Net Income / Employee (TTM)$-75,362

EBITDA Interim CAGR (5Y)-31.39%

ROE (Last FY)-201.89%

Net Interest Coverage (Annual)-2.15x

EPS Basic Excl Extra (Annual)$-3.19

P/FCF (TTM)0.71x

Receivables Turnover (TTM)4.70x

EV / Free Cash Flow (TTM)5.21x

Total Debt / Equity (Quarterly)2.96x

EPS Incl Extra (TTM)$-1.45

Receivables Turnover (Annual)5.04x

ROI (TTM)-21.12%

P/S Ratio (TTM)0.11x

Pretax Margin (5Y Avg)-54.14%

Revenue / Share (Annual)$16.28

Tangible BV / Share (Annual)$0.44

Price vs S&P 500 (52W)-84.41%

Year-to-Date Return-63.46%

5-Day Price Return-18.10%

EPS Normalized (Annual)$-3.19

ROA (5Y Avg)-87.85%

Net Profit Margin (Annual)-19.59%

Month-to-Date Return-30.15%

Cash Flow / Share (TTM)$-0.78

EBITD / Share (Annual)$-2.84

Operating Margin (Annual)-18.94%

LT Debt / Equity (Annual)0.09x

P/CF (TTM)1.43x

ROI (5Y Avg)-175.36%

LT Debt / Equity (Quarterly)0.06x

EPS Basic Excl Extra (TTM)$-1.45

P/TBV (Quarterly)3.28x

P/B Ratio (Annual)1.91x

Inventory Turnover (TTM)6.28x

Pretax Margin (TTM)-11.96%

Book Value / Share (Annual)$1.20

Price vs S&P 500 (13W)-53.90%

Beta2.25x

Revenue / Share (TTM)$12.49

ROE (TTM)-79.48%

52-Week Low$0.34

vGradeA

gGradeB

mGradeF

vgmGradeC

IMCC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2024	Mar 31, 2025	-$11.46	-$4.67	+59.26%(+$6.79)
Q3 2024	Nov 14, 2024	-$20.38	-$8.70	+57.29%(+$11.68)
Q2 2024	Aug 14, 2024	-$24.84	-$4.88	+80.34%(+$19.96)
Q1 2024	May 8, 2024	-$25.47	-$53.50	-110.00%(-$28.02)

IMCC Analyst Recommendations

Jul 2023

Aug 2023

Sep 2023

Oct 2023

4.14

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
IMCCIM Cannabis Corp. Common Shares	A	B	F	0.1x	12.7%	18.6%	—	$1.39
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	B	—	—	—	—	$9.59
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	B	—	—	—	—	$32.10
TRLVTrulieve Cannabis Corp.	B	C	A	1.7x	-3.9%	59.5%	—	$10.01
CRONCronos Group Inc. Common Share	C	B	A	6.6x	37.5%	46.5%	-50.0%	$3.21
TLRYTilray Brands, Inc. Common Stock	B	B	D	0.5x	15.9%	29.1%	—	$3.04
CGCCanopy Growth Corporation Common Shares	B	C	D	1.6x	6.8%	28.5%	—	$0.71
SNDLSundial Growers Inc. Common Shares	B	C	B	0.5x	-1.7%	26.2%	—	$1.25
GLASGlass House Brands Inc.	B	C	D	1.2x	-25.6%	30.8%	—	$3.19
USNAUSANA Health Sciences Inc	B	D	C	0.3x	5.7%	77.5%	-37.0%	$15.54
ACBAurora Cannabis Inc. Common Shares	B	D	B	1.3x	-18.9%	6.3%	—	$3.99
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	1.5x	11.0%	64.2%	—	$2.49
MDWDMediWound Ltd.	D	F	C	12.9x	-40.3%	15.5%	—	$11.85
FTLFFitLife Brands, Inc. Common Stock	B	C	C	0.8x	17.0%	36.5%	-20.0%	$8.39
BTMDBiote Corp. Class A Common Stock	A	D	D	0.2x	-7.8%	68.6%	-26.8%	$1.08
MTEXMannatech Inc.	B	D	B	0.1x	-5.0%	76.1%	-0.8%	$7.13
BONBon Natural Life Limited Class A Ordinary Shares	A	D	C	0.5x	-12.9%	22.1%	—	$1.14
NAIINatural Alternatives International Inc.	A	C	D	0.1x	9.8%	6.3%	—	$1.15
AKANAkanda Corp. Common Shares	C	F	F	12.2x	-63.1%	-60.5%	—	$1.20
SNYRSynergy CHC Corp. Common Stock	A	C	F	0.0x	8.3%	65.4%	118.4%	$0.03
MEHAFunctional Brands, Inc. Common Stock	A	C	C	0.0x	—	53.7%	—	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	B	—	—	—	—	$23.11

About IM Cannabis Corp. Common Shares

IM Cannabis Corp is a Canada-based medical cannabis producer operating through Focus Medical Herbs Ltd, which cultivates and supplies medical cannabis products. The company generates the majority of its revenues from medical cannabis sales to Israeli customers, with additional revenues from sales in Germany.